Ablative therapies for colorectal liver metastases

Area of Science:

• Oncology
• Hepatobiliary Surgery
• Interventional Radiology

Background:

• Colorectal liver metastases (CLM) are common and often require multidisciplinary management.
• Surgical resection is the primary curative option, but many patients are not candidates.
• Ablative therapies provide an alternative or adjunct treatment modality for unresectable CLM.

Purpose of the Study:

• To review the current landscape of ablative therapies for colorectal liver metastases.
• To discuss the rationale, mechanisms, techniques, and outcomes of these treatments.
• To highlight emerging ablative modalities in the management of unresectable CLM.

Main Methods:

• Comprehensive literature review of ablative techniques for CLM.
• Analysis of studies reporting on radiofrequency ablation, microwave ablation, cryoablation, and laser ablation.
• Inclusion of data on emerging techniques such as irreversible electroporation and focused ultrasound.
• Evaluation of reported complication rates and patient outcomes.

Main Results:

• Ablative therapies are effective in achieving local tumor control for unresectable CLM.
• Techniques vary, with different modalities offering specific advantages and disadvantages.
• Complication rates are generally acceptable and manageable.
• Emerging technologies show promise for improved efficacy and safety.

Conclusions:

• Ablative therapies are a crucial component in the multidisciplinary approach to unresectable colorectal liver metastases.
• Selection of the appropriate ablative modality depends on tumor characteristics and patient factors.
• Continued research and technological advancements are expanding the role of ablation in liver cancer treatment.